News & Events

Recent News from IntegriChain


July 28, 2020

IntegriChain Supports 72% of YTD 2020 Life Sciences Launches

IntegriChain's ICyte Platform, the leading launch readiness platform for Market Access data, advisory, and managed services, has supported 72% of NDA and BLA launches so far this year. Life Sciences manufacturers of all size and complexity rely on the ICyte market access and commercialization platform, offering world-class channel and patient data aggregation and stewardship, the largest offering of contracts and pricing managed services to stand up their business infrastructure, gross-to-net forecasting and accrual systems, and launch and pricing transparency advisory. 



June 25, 2020

IntegriChain Appoints Experienced Product Leader to Guide Data Products and Analytics Platform

IntegriChain appoints Dharma Subramanian, a seasoned product leader, as Vice President, Data Products and ICyte Analytics. Subramanian delivers more than 15 years of product management and leadership including roles at Reltio, Veeva Systems, IBM, and Unisys. At IntegriChain, he will be responsible for the company’s channel and patient data and analytics products as well as the unified ICyte access data and business process platform. 



May 18, 2020

IntegriChain Featured in Gartner’s Market Guide for Revenue Management

IntegriChain is prominently featured in Gartner’s new Market Guide for Revenue Management in Pharmaceuticals and Biotechnology, which is available here from the Gartner.com website. Following IntegriChain’s acquisition of the Life Sciences Division of Cumberland last month, the report highlights the combined company’s flexible and agile revenue management data, analytics, and managed services platform.


April 21, 2020

IntegriChain Appoints Experienced HR Leader Vickie Kozhushchenko as SVP, People and Culture

IntegriChain has appointed a highly seasoned human resources executive as Senior Vice President of People and Culture. Vickie Kozhushchenko delivers more than 20 years of global HR experience, including senior executive roles at Clean Earth, Aramark, Turner Broadcasting System, Comcast and Coordinated Health and extensive acquisition integration experience.  She is responsible for IntegriChain’s global HR organization, including the organization’s team development, recruiting and retention programs and policy. 


April 13, 2020

IntegriChain Acquires the Life Sciences Division of Cumberland, Creating the Largest Data and Business Process Platform for Market Access and Commercialization of Specialty, Precision, and Retail Pharmaceuticals

IntegriChain has acquired Cumberland’s Life Science Division, a leading provider of managed services, advisory services and systems integration for contracts, pricing and revenue management. With this acquisition, IntegriChain delivers the Life Science industry’s most comprehensive and scalable data and business process platform for commercialization and market access of cell and gene therapy, specialty, and retail pharmaceuticals.


January 8, 2020

IntegriChain Supported 65+ Life Sciences Launches in Last 36 Months

IntegriChain today announced that the company has supported more than 65 launches of innovative therapies including cell and gene therapy (CGT) and orphan & rare diseases (ORD) during the last three years. Emerging Life Sciences manufacturers have engaged IntegriChain for its best-in-class comprehensive commercialization platform, including channel and patient data stewardship and managed services to stand up their business infrastructure for all aspects of patient access: contracts and pricing, gross-to-net, channel, and patient services.


December 3, 2019

IntegriChain Implements Data-Science-Driven Stewardship of Specialty Pharmacy Data for Multiple Top-30 Life Sciences Manufacturers

IntegriChain announced that multiple top-30 Life Sciences manufacturers have implemented its stewardship and refining solutions to improve the quality and actionability of specialty pharmacy data. These solutions, based on recent data science advancements in the ICyte Platform, overcome the industry challenge of immature patient data sets that includes non-standardize data from hundreds of data suppliers delivered with varied quality. IntegriChain Co-Founder and EVP Josh Halpern will present more on this topic during his presentation, “The State of Patient Status Visibility and the Use of Artificial Intelligence to Drive Specialty Channel Insights,” at CBI Trade & Channel, beginning today in Philadelphia.


adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand